EP1: A novel rabbit monoclonal antibody for detection of oestrogen receptor α

Journal of Clinical Pathology

Volumn 66, Issue 12, 2013, Pages 1051-1057

  Badve, Sunil ^a   Vladislav, Tudor ^a   Spaulding, Betsy ^b   Strickland, Anna ^b   Hernandez, Sylvia ^a   Bird Turner, Lisa ^a   Dodson, Cecelia ^a   Elleby, Bjorn ^b   Phillips, Therese ^b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b AGILENT TECHNOLOGIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR ALPHA; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 1D5; MONOCLONAL ANTIBODY EP1; MONOCLONAL ANTIBODY ER 2 123; MONOCLONAL ANTIBODY SP1; UNCLASSIFIED DRUG; ANTIBODY; DIAGNOSTIC AGENT; ESTROGEN RECEPTOR ALPHA, HUMAN; TUMOR MARKER; DIAGNOSTIC KIT;

ARTICLE; BREAST CARCINOMA; CANCER PATIENT; CANCER TISSUE; CLONE; CONTROLLED STUDY; CYTOPLASM; EPITOPE MAPPING; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MEDICAL DEVICE; PRIORITY JOURNAL; STAINING; TISSUE MICROARRAY; AMINO ACID SEQUENCE; ANIMAL; BREAST CANCER; BREAST TUMOR; COHORT ANALYSIS; COMPARATIVE STUDY; DIAGNOSTIC KIT; ENZYME IMMUNOASSAY; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; MOUSE; PATHOLOGY; RABBIT; DIAGNOSTIC USE;

ANTIBODIES; BREAST CANCER; IMMUNOHISTOCHEMISTRY;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; BREAST NEOPLASMS; COHORT STUDIES; EPITOPE MAPPING; ESTROGEN RECEPTOR ALPHA; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOHISTOCHEMISTRY; MICE; MOLECULAR SEQUENCE DATA; RABBITS; REAGENT KITS, DIAGNOSTIC; TUMOR MARKERS, BIOLOGICAL;

EID: 84892763754     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jclinpath-2012-201391     Document Type: Article

References (24)

1. Manni A, Arafah B, Pearson OH. Estrogen and progesterone receptors in the prediction of response of breast cancer to endocrine therapy. Cancer 1980;46:2838-41.
2. Osborne CK, Yochmowitz MG, Knight WA III, et al. The value of estrogen and progesterone receptors in the treatment of breast cancer. Cancer 1980;46:2884-8.
3. Harvey JM, Clark GM, Osborne CK, et al. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 1999;17:1474-81.
4. Abe O, Abe R, Enomoto K, et al. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005;365:1687-717.
5. Early Breast Cancer Trialists' Collaborative G, Clarke M, Coates AS, et al. Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials. Lancet 2008;371:29-40.
6. Pertschuk LP, Feldman JG, Kim YD, et al. Estrogen receptor immunocytochemistry in paraffin embedded tissues with ER1D5 predicts breast cancer endocrine response more accurately than H222Sp gamma in frozen sections or cytosol-based ligand-binding assays. Cancer 1996;77:2514-19.
7. Taylor CR. Paraffin section immunocytochemistry for estrogen receptor - The time has come. Cancer 1996;77:2419-22.
8. Allred D, Harvey J, Berardo M, et al. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 1998;11:155-68.
9. Collins LC, Botero ML, Schnitt SJ. Bimodal frequency distribution of estrogen receptor immunohistochemical staining results in breast cancer: an analysis of 825 cases. Am J Clin Pathol 2005;123:16-20.
10. Hammond M, Hayes D, Dowsett M, et al. American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol 2010;28:2784-95.
11. Fitzgibbons PL, Murphy DA, Hammond ME, et al. Recommendations for validating estrogen and progesterone receptor immunohistochemistry assays. Arch Pathol Lab Med 2010;134:930-5.
12. Charbgoo F, Mirshahi M, Sarikhani S, et al. Synthesis of a unique high-performance poly-horseradish peroxidase complex to enhance sensitivity of immunodetection systems. Biotechnol Appl Biochem 2012;59:45-9.
13. Rossi S, Laurino L, Furlanetto A, et al. Rabbit monoclonal antibodies: a comparative study between a novel category of immunoreagents and the corresponding mouse monoclonal antibodies. Am J Clin Pathol 2005;124:295-302.
14. Slootstra JW, Puijk WC, Ligtvoet GJ, et al. Structural aspects of antibody-antigen interaction revealed through small random peptide libraries. Mol Divers 1996;1:87-96.
15. Hammond ME, Hayes DF, Dowsett M, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. Arch Pathol Lab Med 2010;134:907-22.
16. Elledge RM, Fuqua SAW. Estrogen and progesterone receptors. In: Harris JR, Lippman ME, Morrow M, Osborne CK.eds Diseases of the breast. New York: Lippincott Williams & Wilkins, 2000:471-85.
17. Gomez-Fernandez C, Mejias A, Walker G, et al. Immunohistochemical expression of estrogen receptor in adenocarcinomas of the lung: the antibody factor. Appl Immunohistochem Mol Morphol 2010;18:137-41.
18. Nadji M, Gomez-Fernandez C, Ganjei-Azar P, et al. Immunohistochemistry of estrogen and progesterone receptors reconsidered: experience with 5,993 breast cancers. Am J Clin Path 2005;123:21-7.
19. Fadare O, Yi X, Liang SX, et al. Variations of mitotic index in normal and dysplastic squamous epithelium of the uterine cervix as a function of endometrial maturation. Mod Pathol 2007;20:1000-8.
20. Brodowska A, Laszczynska M, Starczewski A, et al. Immunohistochemical analysis of steroid receptors in ovaries of postmenopausal women - effects of aging and hormone status. Histol Histopathol 2010;25:1009-16.
21. Deroo BJ, Korach KS. Estrogen receptors and human disease. J Clin Invest 2006;116:561-70.
22. Jones RK, Bulmer JN, Searle RF. Immunohistochemical characterization of proliferation, oestrogen receptor and progesterone receptor expression in endometriosis: comparison of eutopic and ectopic endometrium with normal cycling endometrium. Hum Reprod 1995;10:3272-9.
23. Shiraski H, Watanabe K, Sato J, et al. Expression of steroid receptors in palatine tonsils. Int Congress Ser 2003;1257:115-18.
24. Welsh AW, Moeder CB, Kumar S, et al. Standardization of estrogen receptor measurement in breast cancer suggests false-negative results are a function of threshold intensity rather than percentage of positive cells. J Clin Oncol 2011;29:2978-84.